Abstract
Objective To determine the prevalence of polycystic ovary syndrome (PCOS) among hyperandrogenic women who report normal menses.
Design Prospective observational study.
Setting Academic practice in reproductive endocrinology.
PATIENT(S): Fifty-eight consecutively seen new patients with hyperandrogenism who reported normal menses.
INTERVENTION(S): Ovulatory status was assessed with timed serum progesterone measurements. The following tests also were carried out: vaginal ultrasound examination; measurement of the ovarian response of 17-hydroxyprogesterone (17-OHP) after the administration of leuprolide acetate, 1 mg SC; and determination of fasting serum LH, FSH, E2, 17-OHP, insulin, and androgen levels.
MAIN OUTCOME MEASURE(S): Determination of ovulatory status, polycystic appearance of ovaries, and increased response of 17-OHP to leuprolide acetate.
RESULT(S): Twelve (20.7%) of the hyperandrogenic women were anovulatory and met the usual criteria for the diagnosis of PCOS. The ovulatory patients had lower serum total and unbound testosterone levels. Thirty-one (53.4%) of the ovulatory women had polycystic ovaries on ultrasound examination and/or an increased 17-OHP response to leuprolide acetate, suggesting the diagnosis of PCOS despite the presence of ovulation. Considering both the anovulatory and ovulatory patients, 74% of the hyperandrogenic women studied could have PCOS.
CONCLUSION(S): The data suggest that most (74%) hyperandrogenic women who report normal menses have evidence for the diagnosis of PCOS.
hyperandrogenism normal menstrual cycles, pcos with regular periods, ovulatory pcos diagnosis, polycystic ovaries ovulating women, 17-hydroxyprogesterone leuprolide test, timed progesterone ovulation assessment, androgen excess regular menses, ultrasound pcos diagnosis ovulatory, hyperandrogenic women ovulation testing, prevalence pcos normal cycles
Keywords
17-alpha-Hydroxyprogesterone/metabolism, Adult, Case-Control Studies, Female, Humans, Hyperandrogenism/etiology, Menstrual Cycle/physiology, Ovary/pathology, Ovulation/physiology, Polycystic Ovary Syndrome/complications/epidemiology/pathology, Prevalence, Prospective Studies, Receptors, LHRH/agonists, Receptors, LHRH, 17-alpha-Hydroxyprogesterone,